U.S. Bancorp announces quarterly dividends
MINNEAPOLIS–(BUSINESS WIRE)–The Board of Directors of U.S. Bancorp (NYSE: USB) has declared a regular quarterly dividend of $0.50 per common share, payable... Read more.
VerticalScope Announces Voting Results From Its Annual General Meeting of Shareholders
TORONTO–(BUSINESS WIRE)–VerticalScope Holdings Inc. (“VerticalScope” or the “Company”) (TSX: FORA; OTCQX: VFORF) announced today the voting results... Read more.
Lumentum Unveils PicoBlade® Core for Precision Manufacturing Across Wide Range of Applications and Markets
Ultrafast laser platform provides high throughput, compact footprint, and configurability across IR, green, and UV wavelengths SAN JOSE, Calif.–(BUSINESS WIRE)–Lumentum... Read more.
Satellos Bioscience Shareholders Elect Two New Board Members
TORONTO–(BUSINESS WIRE)–Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a biotech company developing new small... Read more.
Algonquin Power & Utilities Corp. Names Amy Walt Chief Customer Officer
OAKVILLE, Ontario–(BUSINESS WIRE)–$AQN–Algonquin Power & Utilities Corp. (TSX/NYSE: AQN) (“AQN”, “Algonquin” or the “Company”)... Read more.
ISS Recommends ECAT Shareholders Vote to Support Nine out of Ten Board Nominees and Against Saba’s Termination Proposal
ISS Joins Glass Lewis as Second Proxy Advisor to Recommend Shareholders Vote on the WHITE Card Ahead of June 26 Meeting NEW YORK–(BUSINESS WIRE)–BlackRock... Read more.
AM Best Affirms Credit Ratings of Seguros El Roble, S.A.
MEXICO CITY–(BUSINESS WIRE)–#insurance—AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating... Read more.
Schneider recognizes over 200 drivers for outstanding commitment to safety
Additionally, the company achieved a record-breaking milestone in 2024 GREEN BAY, Wis.–(BUSINESS WIRE)–Safety isn’t just a priority at Schneider; it’s... Read more.
Incyte Announces FDA Approval of Monjuvi® (tafasitamab-cxix) in Combination with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma
– Monjuvi® (tafasitamab-cxix) in combination with rituximab and lenalidomide is the first FDA-approved CD19- and CD20-targeted immunotherapy combination for... Read more.
AM Best Affirms Issue Credit Ratings of Weston2038 LLC’s Credit-Linked Notes
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has affirmed the Long-Term Issue Credit Rating (Long-Term IR) of “a” (Excellent) on the $846... Read more.